Beiersdorf AG header image

Beiersdorf AG

BEI

Equity

ISIN DE0005200000 / Valor 324660

Xetra (2024-11-21)
EUR 121.15+0.54%

Beiersdorf AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Beiersdorf AG is a global company with a business segment called tesa, which has been operating independently since 2001. tesa is a leading manufacturer of self-adhesive product solutions for industrial customers and consumers, known for its superior technology and high-quality products. The company's business strategy is centered around innovation, constantly working to develop effective solutions for its customers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

In the first half of 2024, Beiersdorf AG reported a 7.1% increase in organic Group sales compared to the same period in the previous year. This growth was driven by strong performance in both the Consumer Business Segment and the tesa Business Segment. Nominal Group sales rose by 4.8%, reaching €5,175 million, up from €4,936 million in the first half of 2023.

Consumer Business Segment

Beiersdorf AG's Consumer Business Segment saw an 8.0% increase in organic sales in the first half of 2024. This segment's nominal sales grew by 5.4%, amounting to €4,331 million, compared to €4,108 million in the same period of the previous year. The strong performance was attributed to the excellent results of NIVEA and the Derma brands.

Profit After Tax

For the first half of 2024, Beiersdorf AG reported a profit after tax of €590 million, slightly up from €589 million in the same period of 2023. This marginal increase reflects the company's ability to maintain profitability despite various market challenges and cost increases.

EBIT Margin

Beiersdorf AG's EBIT margin excluding special factors stood at 16.2% for the first half of 2024, down from 17.3% in the same period of the previous year. The decrease was primarily due to cost increases related to foreign exchange rate developments, although these were partially offset by price increases and focused spending in marketing, research and development, and digitalization.

Regional Performance

In the first half of 2024, Beiersdorf AG achieved organic sales growth of 5.5% in Europe, 3.0% in the Americas, and 13.5% in the Africa/Asia/Australia region. Nominal sales in these regions were €2,331 million, €1,344 million, and €1,500 million, respectively. The strong performance in the Africa/Asia/Australia region was a significant contributor to the overall growth in Group sales.

Summarized from source with an LLMView Source

Key figures

-3.39%1Y
29.5%3Y
16.2%5Y

Performance

15.4%1Y
18.6%3Y
20.3%5Y

Volatility

Market cap

31332 M

Market cap (USD)

Daily traded volume (Shares)

164,086

Daily traded volume (Shares)

1 day high/low

121.45 / 120.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Mochida Seiyaku KK
Mochida Seiyaku KK Mochida Seiyaku KK Valor: 762797
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.84%JPY 3,320.00
Interparfums Inc
Interparfums Inc Interparfums Inc Valor: 833467
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.78%USD 130.66
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%USD 597.49
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 57.10
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%USD 332.24
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 390.14
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.66%USD 197.60
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 25.04
Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc Bio-Rad Laboratories Inc Valor: 912793
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%USD 325.58
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd Valor: 758744
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%USD 17.08